Posts

Understanding of early life ecosystems highlighted in n...

STARKVILLE, Miss.—With a new understanding of past life on the planet through fo...

Salk Professor Rusty Gage awarded 2024 Taylor Internati...

LA JOLLA (August 14, 2024)—Professor Rusty Gage has been awarded the 2024 J. All...

Using AI to find the polymers of the future

Nylon, Teflon, Kevlar. These are just a few familiar polymers — large-molecule c...

Heart data unlocks sleep secrets

We know that quality sleep is as essential to survival as food and water. Yet, d...

Porous-DeepONet: A deep learning framework for efficien...

Porous media play a critical role in various industrial fields due to their comp...

Novel ratchet with geometrically symmetric gear driven ...

The ratchet mechanism is a fascinating energy-conversion system that converts di...

New computational methodology to predict the complex fo...

Researchers from the group of Prof. Carles Bo, at the Institute of Chemical Rese...

Researchers develop an instant version of trendy, golde...

DENVER, Aug. 18, 2024 — If you’ve visited a trendy café in the past few years, y...

Evidence stacks up for poisonous books containing toxic...

DENVER, Aug. 18, 2024 — If you come across brightly colored, cloth-bound books f...

Peering into the mind of artificial intelligence to mak...

DENVER, Aug. 18, 2024 — Artificial intelligence (AI) has exploded in popularity....

Ascendis Receives a Grudging FDA Approval for Yorvipath...

Ascendis Pharma should be in a good position to launch its hormone replacement t...

AstraZeneca wins approval for Imfinzi in NSCLC perioper...

The FDA approval of Imfinzi in this indication comes a month after the agency ca...

Bavarian Nordic seeks authorisation for mpox vaccine’s ...

Bavarian Nordic aims to gain a label expansion for adolescents in Europe in Q4 t...

Armed with Phase III win, Incyte eyes label expansion f...

The Phase III inMIND trial evaluating Monjuvi as a combination treatment in rela...

Lykos cuts team by 75%, vows to keep MDMA program despi...

The FDA rejected the therapy after the AdCom raised efficacy and ethical concern...

Hoth and Aronnax partner for HT-KIT cancer therapy deve...

Hoth Therapeutics has announced a master services agreement with Aronnax to adva...